Clinical Trial · NCT02995889

FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer

Overview

This study investigates the feasibility of FLT-PET to improve the diagnosis of relapse in patients with irradiated lung cancer in comparison with FDG-PET/CT.

Phase

N/A

Contacts

Andreas Kjær, MD phD MDSci (STUDY_CHAIR)

ClinicalTrials.gov

NCT02995889

Eligibility

Inclusion

  • written and oral consent
  • history with lung cancer, small cell or non-small cell
  • radiotherapy might be normofractionated or stereotactic
  • radiotherapy of lung cancer ended within the last 24 months
  • current suspicion of relapse

Exclusion

  • communication difficulties
  • pregnancy or lactation